Auctus Biologics raised $1.5 million to convert injections with pills
by brian wang from NextBigFuture.com on (#3ZFVV)
Auctus Biologics, a new portfolio company of Ichor Therapeutics, announced the closure of $1.5 million in seed funding. The company will develop RPtag, a hyper-stable antibody mimetic scaffold...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]